Psychedelic Treatments May be Key in Helping Resolve Health Issues

Houston, Texas--(Newsfile Corp. - May 20, 2020) - Psychedelic drugs have been largely misunderstood for years.

However, it appears that's quickly changing thanks to new evidence from the medical community. All on evidence such treatments can improve obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, eating disorders, depression, anxiety, and even smoking.

For example, in recent months, Johns Hopkins Medicine announced the launch of the Center for Psychedelic and Consciousness Research to study compounds like LSD and psilocybin to treat a range of mental health problems, including anorexia, addiction and depression.

A 2017 study featured in the journal, Nature -- Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms - showed that 47% of treatment-resistant patients with depression showed positive responses five weeks after psilocybin treatments. Researchers at New York University found psilocybin mushrooms caused a "rapid and sustained" reduction in anxiety and depression in patients with cancer, as reported by the Financial Post.

Psychiatrists at Johns Hopkins University even found that mushrooms can help with smoking cessation, and another study found it can assist with alcohol dependence.

Psilocybin May Even Help Address the Global Obesity Epidemic

Aside from issues such as PTSD, depression, anxiety, obsessive compulsive disorder, chronic pain, psychedelics may even assist in treating obesity. Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) subsidiary NeonMind Biosciences Inc. is also nearing studies to confirm that it may be an effective treatment for weight loss and food craving.

NeonMind also filed a U.S. provisional patent application to protect intellectual property relating to the use of compounds found in psychedelic mushrooms to lose weight.

NeonMind's pending patent includes the use of psilocybin to help with weight loss, reduce food cravings, counter compulsive eating, improve quality of diet, increase metabolism, treat diabetes, regulate blood glucose levels, and help reduce susceptibility to cardiovascular disease, high blood pressure, and other issues associated with diabetes.

The company hopes to tap into multi-billion-dollar market opportunities, including the $245 billion weight loss and management market, $64 billion cardiovascular disease treatments, the $156 billion depression market, and the $87 billion diabetes treatment market.

For more information, visit the company's website at

About MarijuanaStox is a leading web destination for all cannabis related companies. Investors can also find current marijuana-related quality financial, medical, legal and social news. is a media agency in North America dedicated to the cannabis industry, helping companies that operate in the space to attract quality investors, working capital and real publicity. Since 2005, we have had public companies in the US and Canada have rely on us to grow and succeed.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of and The Yield Growth Corp, Winning Media has been paid four thousand dollars for advertising and marketing services for The Yield Growth Corp. We own ZERO shares of The Yield Growth Corp. Please click here for full disclaimer.

Contact Information:

To view the source version of this press release, please visit